Journal
RHEUMATOLOGY
Volume 49, Issue 9, Pages 1618-1631Publisher
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/keq045
Keywords
Neutrophils; Inflammation; Rheumatoid arthritis; Cytokines; Chemokines; MHC Class II; Apoptosis; TNF; IL-6; Biologics
Categories
Funding
- Charitable Trust of the Royal Liverpool
- Broadgreen Hospital Charitable Trust
Ask authors/readers for more resources
In inflammatory conditions such as RA, the neutrophil has tended to be dismissed as a short-lived, terminally differentiated, irrelevant bystander cell. However, this is clearly not the case. A better understanding of the complex heterogeneous pathways and processes that constitute RA, in parallel with a more sophisticated knowledge of neutrophil biology has identified many potential roles for these cells in the persistence of inflammation and progression of joint damage, which should not be underestimated. Not only are neutrophils found in high numbers within the rheumatoid joint, both in synovial tissue and in joint fluid, they have a huge potential to directly inflict damage to tissue, bone and cartilage via the secretion of proteases and toxic oxygen metabolites, as well as driving inflammation through antigen presentation and secretion of cytokines, chemokines, prostaglandins and leucotrienes. Drugs already used to treat RA down-regulate many neutrophil functions, including migration to the joint, degranulation and production of inflammatory mediators, and these cells should be considered as important targets for the development of new therapies in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available